| Arinder Chadha Md Inc. | |
|
327 Tomko Way Placentia CA 92870-8232 | |
| (714) 996-0599 | |
| (714) 984-8120 |
| Full Name | Arinder Chadha Md Inc. |
|---|---|
| Speciality | Internal Medicine |
| Location | 327 Tomko Way, Placentia, California |
| Authorized Official Name and Position | Arinder Chadha (OWNER) |
| Authorized Official Contact | 7149960599 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Arinder Chadha Md Inc. 327 Tomko Way Placentia CA 92870-8232 Ph: (714) 996-0599 | Arinder Chadha Md Inc. 327 Tomko Way Placentia CA 92870-8232 Ph: (714) 996-0599 |
| NPI Number | 1821220989 |
|---|---|
| Provider Enumeration Date | 08/21/2009 |
| Last Update Date | 08/21/2009 |
| Medicare PECOS PAC ID | 3971640608 |
|---|---|
| Medicare Enrollment ID | O20091028000496 |
News Archive
Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson's and cardiovascular disease; to engineer nanomaterials for use as artificial tissues that would replace diseased kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821220989 | NPI | - | NPPES |
| 00A776110 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Arinder Chadha |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1467480137 PECOS PAC ID: 5193611051 Enrollment ID: I20040226000513 |
News Archive
Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson's and cardiovascular disease; to engineer nanomaterials for use as artificial tissues that would replace diseased kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
› Verified 8 days ago
| Provider Name | Ramon Jocom |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790174761 PECOS PAC ID: 5799001293 Enrollment ID: I20150227000704 |
News Archive
Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson's and cardiovascular disease; to engineer nanomaterials for use as artificial tissues that would replace diseased kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
› Verified 8 days ago
| Provider Name | Reni R Mathew |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588014476 PECOS PAC ID: 3577842251 Enrollment ID: I20161121001586 |
News Archive
Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson's and cardiovascular disease; to engineer nanomaterials for use as artificial tissues that would replace diseased kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
› Verified 8 days ago
| Provider Name | David Bagtas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851748743 PECOS PAC ID: 0840577730 Enrollment ID: I20170502001341 |
News Archive
Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson's and cardiovascular disease; to engineer nanomaterials for use as artificial tissues that would replace diseased kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
› Verified 8 days ago
| Provider Name | Deborah Elizabeth Linton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851925754 PECOS PAC ID: 3577962950 Enrollment ID: I20210604002610 |
News Archive
Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson's and cardiovascular disease; to engineer nanomaterials for use as artificial tissues that would replace diseased kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
› Verified 8 days ago
| Provider Name | Nilza Wangmo Lal |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568917524 PECOS PAC ID: 3779862644 Enrollment ID: I20210715003450 |
News Archive
Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson's and cardiovascular disease; to engineer nanomaterials for use as artificial tissues that would replace diseased kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
› Verified 8 days ago
| Provider Name | Lina Ho |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538835079 PECOS PAC ID: 8820494115 Enrollment ID: I20210913001281 |
News Archive
Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson's and cardiovascular disease; to engineer nanomaterials for use as artificial tissues that would replace diseased kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
› Verified 8 days ago
News Archive
Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson's and cardiovascular disease; to engineer nanomaterials for use as artificial tissues that would replace diseased kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.
Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.
› Verified 8 days ago
Chest And Critical Care Consultants Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1325 N Rose Dr, Suite 208, Placentia, CA 92870 Phone: 714-203-1283 Fax: 714-579-1500 | |
Family Health Center Of Placentia Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1041 E Yorba Linda Blvd, Suite 306, Placentia, CA 92870 Phone: 714-577-9500 Fax: 714-577-9504 | |
Twins Physical Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 S Placentia Ave Ste 600, Placentia, CA 92870 Phone: 714-985-9554 | |
Dr. Joseph M. Longnecker, D.o., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1041 E. Yorba Linda Blvd., Suite 306, Placentia, CA 92870 Phone: 714-577-9500 Fax: 714-577-9504 | |
Centers Of Rehabilitation & Pain Medicine Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1041 E Yorba Linda Blvd Ste 210, Placentia, CA 92870 Phone: 714-223-7000 Fax: 833-471-2059 | |
Yorba Linda Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1041 E Yorba Linda Blvd, Suite 306, Placentia, CA 92870 Phone: 714-577-9500 Fax: 714-577-9504 | |
Care One Health Partners Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1041 E Yorba Linda Blvd Ste 210, Placentia, CA 92870 Phone: 949-688-2678 |